Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.6103
+0.0125 (2.09%)
Dec 4, 2025, 4:00 PM EST - Market closed
Xtant Medical Holdings Revenue
Xtant Medical Holdings had revenue of $33.26M in the quarter ending September 30, 2025, with 19.04% growth. This brings the company's revenue in the last twelve months to $133.08M, up 16.88% year-over-year. In the year 2024, Xtant Medical Holdings had annual revenue of $117.27M with 28.44% growth.
Revenue (ttm)
$133.08M
Revenue Growth
+16.88%
P/S Ratio
0.64
Revenue / Employee
$573,634
Employees
232
Market Cap
85.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.27M | 25.96M | 28.44% |
| Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
| Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
| Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
| Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
XTNT News
- 3 days ago - Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine - PRNewsWire
- 23 days ago - Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Xtant Medical Reports Third Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Xtant Medical Announces Commercial Launch of CollagenX™ - PRNewsWire
- 4 weeks ago - Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025 - PRNewsWire
- 3 months ago - Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 4 months ago - Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Xtant Medical Reports Second Quarter 2025 Financial Results - PRNewsWire